Marquette Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.77K Hold
267
– – ﹤0.01% 270
2026
Q2
$9.45K Sell
267
-17
-6% -$502 ﹤0.01% 321
2026
Q1
$7.87K Buy
284
+74
+35% +$1.9K ﹤0.01% 289
2025
Q4
$4.56K Hold
210
– – ﹤0.01% 340
2025
Q3
$3.18K Buy
+210
New +$2.6K ﹤0.01% 420

Other funds holding ROIV

Marquette Asset Management's ROIV Position: Q3 2026 in Review

Marquette Asset Management held its Roivant Sciences (ROIV) position steady in Q3 2026 at 267 shares worth $9.77K. The position accounts for ﹤0.01% of the portfolio, ranked #270.

Marquette Asset Management first reported a position in ROIV in Q3 2025 and has held it in 5 quarters since. 20 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Marquette Asset Management held 267 shares of Roivant Sciences worth $9.77K as of Q3 2026.
  • Marquette Asset Management left its Roivant Sciences share count unchanged in Q3 2026.
  • Roivant Sciences made up ﹤0.01% of Marquette Asset Management's portfolio in Q3 2026, its #270 holding.
  • Marquette Asset Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 5 quarters since.
  • 20 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.